Src激酶介导中性粒细胞胞外陷阱形成在急性胰腺炎中的作用及机制研究
批准号:
82070668
项目类别:
面上项目
资助金额:
54.0 万元
负责人:
路国涛
依托单位:
学科分类:
胰腺外分泌功能异常与胰腺炎
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
路国涛
中文摘要
中性粒细胞胞外陷阱(NETs)介导的过度炎症反应是急性胰腺炎(AP)进展的关键因素之一。NADPH/ROS通路是NETs形成的关键。Src激酶是慢性粒细胞白血病的临床治疗靶点之一,且Src激酶可介导多种信号通路加剧非感染性炎症反应。我们前期研究①RNA-seq显示AP胰腺组织Src激酶显著上调,并验证AP小鼠中性粒细胞Src激酶活化;②Src激酶特异性抑制剂减少AP小鼠NETs生成、降低炎症反应、保护胰腺和肺损伤。我们推测:Src激酶通过NADPH/ROS介导NETs形成,诱发AP过度炎症反应,加剧胰腺和远隔脏器损伤。拟将①观察中性粒细胞Src激酶水平与NETs形成和AP患者预后的相关性;②明确Src激酶对NETs形成、AP炎症反应、胰腺和远隔脏器损伤的调控作用;③阐明Src激酶介导NETs形成的分子机制。本课题从中性粒细胞角度鉴定NETs形成的关键靶点,为AP治疗提供理论依据和实验基础。
英文摘要
The excessive inflammatory response mediated by neutrophil extracellular traps (NETs) is one of the key factors for the progress of acute pancreatitis (AP), and the NADPH / ROS pathway is the key to the formation of NETs. Src kinase is one of the clinical therapeutic targets of chronic myeloid leukemia and it can mediate a variety of signaling pathways to exacerbate non-infectious inflammatory responses. Our previous study found that ①Src kinase in AP pancreas tissue was significantly up-regulated by RNA-seq detection, and verified that Src kinase was activated in neutrophils in AP mice; ②Src kinase specific inhibitor reduced the generation of NETs and inflammatory response in AP pancreatic tissue, also protected the pancreatic tissue injury and related lung injury. Hence, we assume that Src kinase mediates the formation of NETs through NADPH /ROS, so that it could induce the excessive inflammation response of AP and exacerbate the pancreatic tissue and remote organ damage. We will: ① observe the correlation between neutrophil Src kinase level and the formation of NETs and the prognosis of AP patients; ②identify the regulatory role of Src kinase on NETs formation, inflammation response, pancreatic tissue and remote organ damage in AP; ③clarify the molecular mechanism of Src kinase on the formation of NETs. This study will identify a key target for the formation of NETs from the perspective of neutrophil, and provide a theoretical and experimental basis for AP treatment.
中性粒细胞胞外陷阱(NETs)是介导急性炎症损伤的关键因素。然而,其潜在机制和潜在的治疗靶点尚不清楚。先前的研究结果表明,Src激酶可能参与调节NETs的形成。在这里,我们发现Src激酶在体外NETs模型中,在小鼠和人类来源的中性粒细胞(急性胰腺炎和败血症)中被激活。此外,p-Src表达与急性胰腺炎和脓毒症患者的临床预后相关。同时,抑制Src激酶活性(基因沉默或抑制剂)在体外抑制了NETs的形成。从机制上讲,Src激酶通过调节Ser 621位点的磷酸化来激活RAF1,并介导RAF/MEK/ERK通路,从而影响细胞内ROS的产生。在体内,中性粒细胞Src激酶特异性缺陷显著降低了急性炎症反应、器官损伤和受损组织中NETs的形成。最终,我们使用了Src激酶抑制剂(特异性抑制剂及两种非特异性抑制剂)并验证了它们的药理作用。这些结果表明Src激酶是细胞内ROS产生、NETs形成和急性器官损伤的关键介质。因此,抑制Src激酶可能是治疗急性器官损伤的一种有前景的治疗策略。
DOHH调控eIF5A hypusination修饰介导线粒体氧化磷酸化在急性胰腺炎腺泡细胞坏死中的作用和机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:路国涛
-
依托单位:
国内基金
海外基金